No Data
We Think Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Has A Fair Chunk Of Debt
Olin Biotech (688319.SH): received a government subsidy of 2.77 million yuan.
Gelonghui January 22丨Olin Bio (688319.SH) announced that its holding subsidiary Chengdu Xinnuo Ming Biotechnology Co., Ltd. received a total of 2,773,902.60 yuan in government subsidies on January 22, 2025, of which 2,773,902.60 yuan is related to earnings and 0 yuan is related to Assets.
Individual Investors Among Chengdu Olymvax Biopharmaceuticals Inc.'s (SHSE:688319) Largest Stockholders and Were Hit After Last Week's 8.3% Price Drop
Olin Biotech (688319.SH): received a government subsidy of 2.24 million yuan.
Glonghui November 28丨 Olin Bioscience (688319.SH) announced that its wholly-owned subsidiary Chongqing Yuanlun Biological Technology Co., Ltd. recently received government subsidies totaling 2.24 million yuan, with 2.24 million yuan related to income and 0 yuan related to assets.
Chengdu Olin Biotechnology Co., Ltd. Report for the Third Quarter of 2024
Gelonghui Announcement Highlights: PetroChina: Net income in the third quarter was 43.911 billion yuan, a decrease of 5.3% year-on-year; Muyuan Foods: Net income in the first three quarters was 10.481 billion yuan, an increase of 668.90% year-on-year.
【Performance Report】Petrochina (601857.SH): The net income in the third quarter was 43.911 billion yuan, a decrease of 5.3% year-on-year. CNSIG Inner Mongolia Chemical Industry (600328.SH): The net income in the first three quarters was 0.574 billion yuan, a decrease of 31.72% year-on-year. Datang International Power Generation (601991.SH): The net income in the first three quarters was 4.429 billion yuan, an increase of 56.22% year-on-year. Hisense Visual Technology (600060.SH): The net income in the first three quarters was 1.31 billion yuan, a decrease of 19.53% year-on-year. Yunnan Baiyao Group (000538.SZ): The net income in the first three quarters was 4.327 billion yuan, an increase.
Declining Stock and Decent Financials: Is The Market Wrong About Chengdu Olymvax Biopharmaceuticals Inc. (SHSE:688319)?
